相关实验视频
Updated: Jun 14, 2025

11:18
Direct Drug Delivery to Kidney via the Renal Artery
Published on: April 17, 2021
7.2K
基于纳米技术的药物输送系统用于治疗急性损伤
Wanbing Qin1, Jiaqi Huang1, Manting Zhang1
1Jieyang Medical Research Center, Jieyang People's Hospital, Jieyang, 522000 Guangdong, China.
ACS biomaterials science & engineering
|September 3, 2024
概括
新的纳米载体技术为急性损伤 (AKI) 提供了改进的治疗方法,这种疾病的特征是功能迅速下降. 本综述探讨了AKI药物输送纳米医学的进展,强调了潜在的治疗益处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 纳米医学是一种纳米医学.
- 生物医学工程 生物医学工程
背景情况:
- 急性损伤 (AKI) 是住院患者常见且严重的疾病,通常由败血症,低输液或毒剂引起.
- 目前的AKI治疗方法,包括支持性护理和移植,具有局限性和不令人满意的结果.
- 新兴的疗法,如抗氧化剂,铁,抗炎,自和抗瘤疗法,有望改善AKI管理.
研究的目的:
- 审查近期纳米载体开发在急性损伤 (AKI) 中药物输送方面的进展.
- 强调纳米载体设计和改造的最新创新,以提高治疗效果.
- 总结各种纳米载体在治疗AKI中的应用,并讨论它们的临床潜力.
主要方法:
- 文献综述专注于基于纳米载体的药物输送系统,用于AKI.
- 对纳米载体改造和设计策略的最新发展进行分析.
- 调查不同纳米载体在AKI治疗模型中的应用的研究摘要.
主要成果:
- 纳米技术已经显著提升了AKI的治疗方法.
- 新型纳米载体证明了药物输送效率的提高和向治疗效果.
- 各种纳米载体平台正在探索抗氧化剂,抗炎剂和其他向的AKI疗法.
结论:
- 基于纳米载体的药物输送具有革命性的AKI治疗的重大前景.
- 进一步研究纳米载体设计和临床转化对于实现其全部潜力至关重要.
- 几种纳米药物正在进行临床试验,用于治疗病,这表明AKI治疗的前景是积极的.
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Renal Drug Excretion: Tubular Secretion
153
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
153
Renal Failure: Dose Adjustments
69
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
69
Renal Drug Excretion: Tubular Reabsorption
133
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
133
Renal Drug Excretion: Overview
132
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
132
Drug Elimination by Renal Route: Tubular Reabsorption
3.3K
During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...
3.3K

